Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
Christensen O, Lupu A, Schmidt S, Condomines M, Belle S, Maier A, Hose D, Neuber B, Moos M, Kleist C, Terness P, Ho AD, Goldschmidt H, Klein B, Hundemer M.
Christensen O, et al. Among authors: condomines m.
J Immunother. 2009 Jul-Aug;32(6):613-21. doi: 10.1097/CJI.0b013e3181a95198.
J Immunother. 2009.
PMID: 19483648